Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An infection that is caused by nematodes of the genus Strongyloides, most commonly Strongyloides stercoralis, which is a soil-transmitted helminth, and which is characterized by a variety of gastrointestinal, dermatologic, and, occasionally, pulmonary manifestations. The worm's autoinfective life cycle can lead to hyper-infection and life-threatening dissemination in immunocompromised hosts decades after initial infection.
Biomarker and diagnostic research for strongyloidiasis has been reported in the published literature.
1 FDA-approved treatment is available for strongyloidiasis, including IVERMECTIN (STROMECTOL, approved 1996).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
STROMECTOL | IVERMECTIN | — | 1996 | Available |
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
244 publications have been identified in PubMed for strongyloidiasis. Kisho has analyzed 52 by research type. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (17%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 21 |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
1 trial found
Patient case studies | 9 | 17% |
Testing and diagnosis research | 7 | 13% |
Laboratory research | 7 | 13% |
Other research | 3 | 6% |
Disease patterns and progression | 3 | 6% |
Clinical study results | 2 | 4% |
Schlachet A (2026). [PMID: 42086106](https://pubmed.ncbi.nlm.nih.gov/42086106/). *Parasitol Int*. [Case Report / Case Series]
Gebremichael YL (2026). [PMID: 42089110](https://pubmed.ncbi.nlm.nih.gov/42089110/). *IDCases*. [Case Report / Case Series]
Liu Y (2025). [PMID: 40663613](https://pubmed.ncbi.nlm.nih.gov/40663613/). *Proc Natl Acad Sci U S A*. [Epidemiology / Natural History]
Dejon Agobé JC (2025). [PMID: 41364144](https://pubmed.ncbi.nlm.nih.gov/41364144/). *Parasitol Res*. [Basic Science / Preclinical]
Yang R (2025). [PMID: 39142910](https://pubmed.ncbi.nlm.nih.gov/39142910/). *J Microbiol Immunol Infect*. [Review / Meta-Analysis]
Guido G (2025). [PMID: 39983935](https://pubmed.ncbi.nlm.nih.gov/39983935/). *Travel Med Infect Dis*. [Review / Meta-Analysis]
Mace CE (2025). [PMID: 39568332](https://pubmed.ncbi.nlm.nih.gov/39568332/). *J Small Anim Pract*. [Case Report / Case Series]
Boufares YEA (2025). [PMID: 40353499](https://pubmed.ncbi.nlm.nih.gov/40353499/). *Ann Biol Clin (Paris)*. [Case Report / Case Series]
Kang M (2025). [PMID: 39890286](https://pubmed.ncbi.nlm.nih.gov/39890286/). *Clin Chest Med*. [Review / Meta-Analysis]
Tobon Ramos JA (2025). [PMID: 40063867](https://pubmed.ncbi.nlm.nih.gov/40063867/). *PLoS Negl Trop Dis*. [Clinical Trial Publication]
AI-curated news mentioning strongyloidiasis
Updated Sep 8, 2026
A case study highlights a survival instance of pulmonary hemorrhage due to disseminated strongyloidiasis in a patient with systemic lupus erythematosus. This research underscores the complex interplay between these conditions and may inform future clinical approaches.
A retrospective study identifies the rare occurrence of zoonotic Strongyloides stercoralis in dogs in temperate Australia from 2014 to 2024. This finding highlights the potential zoonotic risks associated with this parasite.